Publisher : Science Press
Published Date : 4/2009
Language : Chinese
ISBN/ISSN : 9787030241771
Pages : 243
Weight : 0.70kg
Availability : Usually ship within 48 hours
Book Type : Report
Estimated Shipping Time

"Biomedical Development Strategy (policy papers)," literature research, expert interviews and other intelligence analysis, international pharmaceutical management in the field of international nature and the typical representative of U.S., EU, Japan and China from 2004 to 2008, drugs and comprehensive drug development management policy research, in-depth analysis of national / regional characteristics. Changes from drug laws and regulations, clinical research, drug approval, post-marketing drug testing, drug advertising regulation, management of new therapies, bio-generic drugs, some materials research and development of major diseases, acute critically ill patients access to means of drugs, medicines and other aspects of the development of new technologies the four countries / regions were compared and summarized, and the management of medical innovation in China to make relevant recommendations to further improve our level of scientific management of drugs and promote new drug development, to meet the development needs of the national health strategy. Pharmaceutical industry related to national health standards, and the world economy in the national economy plays an important role. The current status of global pharmaceutical industry is to extend the drug development cycle, R & D investment increases, new products listed without a corresponding increase, or even decline. To meet the new environment, the development needs of the pharmaceutical industry, countries attached great importance to the Chinese Medicine Policy.